1. Home
  2. FIEE vs TELA Comparison

FIEE vs TELA Comparison

Compare FIEE & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FiEE Inc

FIEE

FiEE Inc

HOLD

Current Price

$7.00

Market Cap

45.6M

Sector

Utilities

ML Signal

HOLD

Logo TELA Bio Inc.

TELA

TELA Bio Inc.

HOLD

Current Price

$0.66

Market Cap

37.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FIEE
TELA
Founded
N/A
2012
Country
United States
United States
Employees
43
N/A
Industry
Telecommunications Equipment
Medical/Dental Instruments
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
45.6M
37.5M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
FIEE
TELA
Price
$7.00
$0.66
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$2.50
AVG Volume (30 Days)
18.2K
103.7K
Earning Date
N/A
03-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
37.59
EPS
N/A
N/A
Revenue
N/A
$80,275,000.00
Revenue This Year
N/A
$17.75
Revenue Next Year
N/A
$16.45
P/E Ratio
N/A
N/A
Revenue Growth
N/A
15.84
52 Week Low
$1.50
$0.62
52 Week High
$7.95
$2.19

Technical Indicators

Market Signals
Indicator
FIEE
TELA
Relative Strength Index (RSI) 53.14 39.23
Support Level $6.60 N/A
Resistance Level $7.26 $1.22
Average True Range (ATR) 0.34 0.10
MACD -0.07 -0.01
Stochastic Oscillator 27.02 22.59

Price Performance

Historical Comparison
FIEE
TELA

About FIEE FiEE Inc

FiEE Inc, formerly Minim Inc is a digital service provider focused on integrating artificial intelligence and data analytics into content creation and brand management. The company offers a range of services designed to support creators, artists, and businesses in developing, managing, and optimizing their digital presence across various platforms, including customized graphic and posts, short videos, and editorial calendars aligned with brand goals.

About TELA TELA Bio Inc.

TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.

Share on Social Networks: